Format
Sort by
Items per page

Send to

Choose Destination

Best matches for abdominal bloating AND constipation AND irritable bowel syndrome AND rifaximin:

Antibiotic treatment of constipation-predominant irritable bowel syndrome. Pimentel M et al. Dig Dis Sci. (2014)

Treatment of abdominal pain in irritable bowel syndrome. Vanuytsel T et al. J Gastroenterol. (2014)

Rifaximin therapy for patients with irritable bowel syndrome without constipation. Pimentel M et al. N Engl J Med. (2011)

Search results

Items: 1 to 20 of 21

1.

Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico.

Schmulson MJ, Frati-Munari AC.

Rev Gastroenterol Mex. 2018 Apr 17. pii: S0375-0906(18)30062-4. doi: 10.1016/j.rgmx.2018.02.008. [Epub ahead of print] English, Spanish.

2.

Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management.

Maconi G.

Acta Biomed. 2017 Apr 28;88(1):25-32. doi: 10.23750/abm.v88i1.6360. Review.

3.

Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth?

Long SK, Di Palma JA.

South Med J. 2016 May;109(5):296-9. doi: 10.14423/SMJ.0000000000000454.

PMID:
27135726
4.

New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Foxx-Orenstein AE.

Therap Adv Gastroenterol. 2016 May;9(3):354-75. doi: 10.1177/1756283X16633050. Epub 2016 Feb 21. Review.

5.

[Pain therapy in irritable bowel syndrome].

de Greck M, Layer P, Andresen V.

Schmerz. 2014 Jun;28(3):289-93. doi: 10.1007/s00482-014-1406-6. Review. German.

PMID:
24903042
6.

Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.

Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA.

Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):96-134. doi: 10.1016/j.rgmx.2014.01.004. Epub 2014 May 23. Review. English, Spanish.

7.

Treatment of abdominal pain in irritable bowel syndrome.

Vanuytsel T, Tack JF, Boeckxstaens GE.

J Gastroenterol. 2014 Aug;49(8):1193-205. doi: 10.1007/s00535-014-0966-7. Epub 2014 May 21. Review.

PMID:
24845149
8.

Antibiotic treatment of constipation-predominant irritable bowel syndrome.

Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M.

Dig Dis Sci. 2014 Jun;59(6):1278-85. doi: 10.1007/s10620-014-3157-8. Epub 2014 May 1.

PMID:
24788320
9.

Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.

Cash BD.

Curr Med Res Opin. 2014 Jul;30(7):1405-15. doi: 10.1185/03007995.2014.908278. Epub 2014 Apr 14. Review.

PMID:
24666019
10.

Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.

Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2013 May;17(10):1314-20.

11.

Functional abdominal bloating with distention.

Sullivan SN.

ISRN Gastroenterol. 2012;2012:721820. doi: 10.5402/2012/721820. Epub 2012 Jun 19.

12.

Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.

Strate LL, Modi R, Cohen E, Spiegel BM.

Am J Gastroenterol. 2012 Oct;107(10):1486-93. doi: 10.1038/ajg.2012.194. Epub 2012 Jul 10. Review.

PMID:
22777341
13.

Targeted therapies for diarrhea-predominant irritable bowel syndrome.

Olden KW.

Clin Exp Gastroenterol. 2012;5:69-100. doi: 10.2147/CEG.S29023. Epub 2012 May 25.

14.

[Irritable bowel syndrome--irritable bowel or irritable mind?].

Marlicz W, Zawada I, Starzyńska T.

Pol Merkur Lekarski. 2012 Jan;32(187):64-9. Review. Polish.

PMID:
22400184
15.

Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.

Chey WD, Maneerattaporn M, Saad R.

Gut Liver. 2011 Sep;5(3):253-66. doi: 10.5009/gnl.2011.5.3.253. Epub 2011 Aug 18.

16.

The role of rifaximin therapy in patients with irritable bowel syndrome without constipation.

Schey R, Rao SS.

Expert Rev Gastroenterol Hepatol. 2011 Aug;5(4):461-4. doi: 10.1586/egh.11.50. Review.

PMID:
21780893
17.

Treatment of irritable bowel syndrome.

Trinkley KE, Nahata MC.

J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24. Review.

PMID:
21545610
18.

Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.

Petrone P, Sarkisyan G, Fernández M, Coloma E, Akopian G, Ortega A, Kaufman HS.

Arch Surg. 2011 Apr;146(4):444-7. doi: 10.1001/archsurg.2011.55.

PMID:
21502453
19.

Review article: the treatment of functional abdominal bloating and distension.

Schmulson M, Chang L.

Aliment Pharmacol Ther. 2011 May;33(10):1071-86. doi: 10.1111/j.1365-2036.2011.04637.x. Epub 2011 Mar 29. Review.

20.

Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group.

N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409.

Supplemental Content

Loading ...
Support Center